Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Current Leases (2021 - 2023)

Alx Oncology Holdings' Current Leases history spans 3 years, with the latest figure at $777000.0 for Q1 2023.

  • On a quarterly basis, Current Leases rose 30.37% to $777000.0 in Q1 2023 year-over-year; TTM through Mar 2023 was $777000.0, a 30.37% increase, with the full-year FY2022 number at $755000.0, up 141.21% from a year prior.
  • Current Leases hit $777000.0 in Q1 2023 for Alx Oncology Holdings, up from $755000.0 in the prior quarter.
  • Over the last five years, Current Leases for ALXO hit a ceiling of $777000.0 in Q1 2023 and a floor of $313000.0 in Q4 2021.
  • Historically, Current Leases has averaged $635166.7 across 3 years, with a median of $685000.0 in 2022.
  • Biggest five-year swings in Current Leases: soared 141.21% in 2022 and later skyrocketed 30.37% in 2023.
  • Tracing ALXO's Current Leases over 3 years: stood at $313000.0 in 2021, then soared by 141.21% to $755000.0 in 2022, then rose by 2.91% to $777000.0 in 2023.
  • Business Quant data shows Current Leases for ALXO at $777000.0 in Q1 2023, $755000.0 in Q4 2022, and $724000.0 in Q3 2022.